- $114.22m
- $546.24m
- $186.72m
- 31
- 78
- 47
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 202 | 166 | 212 | 257 | 187 |
Cost of Revenue | |||||
Gross Profit | 12.7 | 11 | 7.94 | -5.54 | 2.02 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 213 | 172 | 227 | 339 | 224 |
Operating Profit | -11.1 | -6.07 | -14.7 | -82.4 | -37.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -38.3 | -37.6 | -47.3 | -107 | -100 |
Provision for Income Taxes | |||||
Net Income After Taxes | -39.5 | -36.7 | -47.1 | -108 | -46.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -35.7 | -36.7 | -47.1 | -108 | -46.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -35.7 | -36.7 | -47.1 | -108 | -46.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.55 | -1.74 | -1.56 | -2.21 | -1.22 |